Biospring Partners invests $10M in Welsh Carson-owned Abzena
Banking Essentials Newsletter: September 18th Edition
Loan Platforms: Securing settlement instructions and prioritising the user experience
Navigating the New Canadian Derivatives Landscape: Key Changes and Compliance Steps for 2025
Getting an Edge with Services: Driving optimization by embracing technological innovation
Newly formed Biospring Partners invested $10 million in Abzena PLC, a life science tools and services company based in the U.K.
Biospring co-founder Michelle Dipp will sit on Abzena's board.
Abzena is owned by private equity firm Welsh Carson Anderson & Stowe and is focused on development and manufacturing of biologics and antibody drug conjugates.
